Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Neoplasms 10Breast Neoplasms 7Colorectal Neoplasms 5Prostatic Neoplasms 4Hematologic Neoplasms 4Melanoma 3Urinary Bladder Neoplasms 2Pancreatic Neoplasms 2Malignant Solid Neoplasm 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Head and Neck Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2COVID-19 2Vaping 1Urologic Neoplasms 1Urologic Diseases 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Speech 1Smoking 1Seroma 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Psoriasis 1Progressive Metastatic Castrate Resistant Prostate Cancer 1

Interventions

cabozantinib 1anifrolumab 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Platinum Compounds 1Nivolumab 1Methods 1Ipilimumab 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lupus Erythematosus, Systemic × Standard of Care × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡